|
PHF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.200500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.919600E-03 |
| Normal-vs-Stage2 |
9.621400E-01 |
| Normal-vs-Stage3 |
6.260800E-01 |
| Normal-vs-Stage4 |
8.840400E-02 |
| Stage1-vs-Stage2 |
3.215800E-01 |
| Stage1-vs-Stage3 |
9.429800E-02 |
| Stage1-vs-Stage4 |
9.958000E-01 |
| Stage2-vs-Stage3 |
8.418400E-01 |
| Stage2-vs-Stage4 |
3.945200E-01 |
| Stage3-vs-Stage4 |
3.594400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.170080E-02 |
| Normal-vs-AfricanAmerican |
2.448400E-01 |
| Normal-vs-Asian |
7.893000E-01 |
| Caucasian-vs-AfricanAmerican |
5.379000E-01 |
| Caucasian-vs-Asian |
2.916400E-01 |
| AfricanAmerican-vs-Asian |
5.608200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.424600E-04 |
| Normal-vs-Female |
2.780800E-01 |
| Male-vs-Female |
9.51019999999581E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.641700E-02 |
| Normal-vs-Extreme_Weight |
2.063500E-03 |
| Normal-vs-Obese |
6.088200E-01 |
| Normal-vs-Extreme_Obese |
6.662500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.618200E-01 |
| Normal_Weight-vs-Obese |
1.759380E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.569800E-01 |
| Extreme_Weight-vs-Obese |
2.536100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.349000E-01 |
| Obese-vs-Extreme_Obese |
4.181000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.177400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.709400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.523900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.795100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.590400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.290300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.723300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.654300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.024400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.726100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.783300E-03 |
| Normal-VS-Type2 PRCC |
7.740800E-03 |
| Normal-VS-KIRP CIMP |
4.490000E-01 |
| Normal-VS-Unclassified PRCC |
9.289000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.853400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.358200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.874100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.311970E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.479900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.957000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.118660E-03 |
| Normal-vs-N1 |
9.752000E-01 |
| Normal-vs-N2 |
7.184400E-01 |
| N0-vs-N1 |
3.230100E-02 |
| N0-vs-N2 |
2.843600E-01 |
| N1-vs-N2 |
8.100400E-01 |
|
|
